fenofibrate has been researched along with Vitreous Hemorrhage in 1 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
Vitreous Hemorrhage: Hemorrhage into the VITREOUS BODY.
Excerpt | Relevance | Reference |
---|---|---|
"This study aimed to determine the association between fenofibrate added to statin therapy and diabetic retinopathy progression." | 8.31 | Addition of fenofibrate to statins is associated with risk reduction of diabetic retinopathy progression in patients with type 2 diabetes and metabolic syndrome: A propensity-matched cohort study. ( Choi, J; Kim, NH; Kim, SG; Kim, YH; Lee, H, 2023) |
"This study aimed to determine the association between fenofibrate added to statin therapy and diabetic retinopathy progression." | 4.31 | Addition of fenofibrate to statins is associated with risk reduction of diabetic retinopathy progression in patients with type 2 diabetes and metabolic syndrome: A propensity-matched cohort study. ( Choi, J; Kim, NH; Kim, SG; Kim, YH; Lee, H, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Kim, NH | 1 |
Choi, J | 1 |
Kim, YH | 1 |
Lee, H | 1 |
Kim, SG | 1 |
1 other study available for fenofibrate and Vitreous Hemorrhage
Article | Year |
---|---|
Addition of fenofibrate to statins is associated with risk reduction of diabetic retinopathy progression in patients with type 2 diabetes and metabolic syndrome: A propensity-matched cohort study.
Topics: Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Fenofibrate; Humans; Hydroxymethylg | 2023 |